Membranous Nephropathy: A Journey from Bench to Bedside

American Journal of Kidney Diseases

Volumn 68, Issue 1, 2016, Pages 138-147

  Francis, Jean M ^a   Beck, Laurence H ^a   Salant, David J ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

class II major histocompatibility; epitope; genetic polymorphisms; M type phospholipase A2 receptor 1 (PLA2R); Membranous nephropathy (MN); nephrotic syndrome; organ specific autoimmunity; PLA2R1; post transplant recurrent disease; thrombospondin type 1 domain containing 7A (THSD7A)

Indexed keywords

EPITOPE; PHOSPHOLIPASE A2 RECEPTOR; THROMBOSPONDIN 1; THROMBOSPONDIN TYPE 1 DOMAIN CONTAINING 7A; UNCLASSIFIED DRUG; AUTOANTIBODY; PLA2R1 PROTEIN, HUMAN;

ANTIBODY TITER; ASSAY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MEMBRANOUS GLOMERULONEPHRITIS; RECURRENT DISEASE; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; BLOOD; CHEMISTRY; IMMUNOLOGY; KIDNEY; MEDICAL RESEARCH; PROGNOSIS;

AUTOANTIBODIES; BIOMEDICAL RESEARCH; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY; PROGNOSIS; RECEPTORS, PHOSPHOLIPASE A2; RECURRENCE;

EID: 84964342102     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.01.030     Document Type: Review

References (84)

1. W.G. Couser, D.R. Steinmuller, M.M. Stilmant, D.J. Salant, and L.M. Lowenstein Experimental glomerulonephritis in the isolated perfused rat kidney J Clin Invest 62 2 1978 1275 1287
2. B.J. Van Damme, G.J. Fleuren, W.W. Bakker, R.L. Vernier, and P.J. Hoedemaeker Experimental glomerulonephritis in the rat induced by antibodies directed against tubular antigens. V. Fixed glomerular antigens in the pathogenesis of heterologous immune complex glomerulonephritis Lab Invest 38 4 1978 502 510
3. W.G. Couser, and D.J. Salant In situ immune complex formation and glomerular injury Kidney Int 17 1 1980 1 13
4. S.P. Makker, and A.K. Singh Characterization of the antigen (gp600) of Heymann nephritis Lab Invest 50 3 1984 287 293
5. R. Raychowdhury, J.L. Nile, R.T. McCluskey, and J.A. Smith Autoimmune target in Heymann nephritis is a glycoprotein with homology to the LDL receptor Science 244 4909 1989 1163 1165
6. D. Kerjaschki, and M.G. Farquhar The pathogenic antigen of Heymann nephritis is a membrane glycoprotein of the renal proximal tubule brush border Proc Natl Acad Sci U S A 79 18 1982 5557 5581
7. D. Kerjaschki, and M.G. Farquhar Immunocytochemical localization of the Heymann nephritis antigen (GP330) in glomerular epithelial cells of normal Lewis rats J Exp Med 157 2 1983 667 686
8. D. Kerjaschki, A. Miettinen, and M.G. Farquhar Initial events in the formation of immune deposits in passive Heymann nephritis J Exp Med 166 1 1987 109 128
9. H. Debiec, V. Guigonis, B. Mougenot, and et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies N Engl J Med 346 26 2002 2053 2060
10. R. Ayalon, and L.H. Beck Jr. Membranous nephropathy: not just a disease for adults Pediatr Nephrol 30 1 2015 31 39
11. L.H. Beck Jr., R.G. Bonegio, G. Lambeau, and et al. M-Type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy N Engl J Med 361 1 2009 11 21
12. H. Debiec, and P. Ronco PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy N Engl J Med 364 7 2011 689 690
13. E. Hoxha, U. Kneissler, G. Stege, and et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy Kidney Int 82 7 2012 797 804
14. N.M. Tomas, L.H. Beck Jr., C. Meyer-Schwesinger, and et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy N Engl J Med 371 24 2014 2277 2287
15. M. Godel, F. Grahammer, and T.B. Huber Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy N Engl J Med 372 11 2015 1073
16. T. Iwakura, N. Ohashi, A. Kato, S. Baba, and H. Yasuda Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy PLoS One 10 9 2015 e0138841
17. J.M. Hofstra, F.C. Fervenza, and J.F. Wetzels Treatment of idiopathic membranous nephropathy Nat Rev Nephrol 9 8 2013 443 458
18. C. Ponticelli, and R.J. Glassock Glomerular diseases: membranous nephropathy-a modern view Clin J Am Soc Nephrol 9 3 2014 609 616
19. D.J. Salant, and D.C. Cattran Membranous nephropathy R.J. Johnson, J. Feehally, J. Floege, Comprehensive Clinical Nephrology 5th ed. 2014 Elsevier Philadelphia, PA 239 252
20. J.M. Hofstra, L.H. Beck Jr., D.M. Beck, J.F. Wetzels, and D.J. Salant Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy Clin J Am Soc Nephrol 6 6 2011 1286 1291
21. E. Hoxha, S. Harendza, H.O. Pinnschmidt, and et al. Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy Nephrol Dial Transplant 30 11 2015 1862 1869
22. S. Akiyama, M. Akiyama, E. Imai, T. Ozaki, S. Matsuo, and S. Maruyama Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy Clin Exp Nephrol 19 4 2015 653 660
23. W. Schlumberger, N. Hornig, S. Lange, and et al. Differential diagnosis of membranous nephropathy with autoantibodies to phospholipase A2 receptor 1 Autoimmun Rev 13 2 2014 108 113
24. C. Dahnrich, L. Komorowski, C. Probst, and et al. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy Clin Chim Acta 421 2013 213 218
25. D. Kanigicherla, J. Gummadova, E.A. McKenzie, and et al. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy Kidney Int 83 5 2013 940 948
26. A. Behnert, M. Schiffer, J. Muller-Deile, L.H. Beck Jr., M. Mahler, and M.J. Fritzler Antiphospholipase A(2) receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy J Immunol Res 2014 2014 143274
27. P. Ronco, and H. Debiec Pathogenesis of membranous nephropathy: recent advances and future challenges Nat Rev Nephrol 8 4 2012 203 213
28. X. Huang, W. Qin, M. Zhang, C. Zheng, C. Zeng, and Z. Liu Detection of anti-PLA2R autoantibodies and IgG subclasses in post-allogeneic hematopoietic stem cell transplantation membranous nephropathy Am J Med Sci 346 1 2013 32 37
29. W. Qin, L.H. Beck Jr., C. Zeng, and et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy J Am Soc Nephrol 22 6 2011 1137 1143
30. M. Dauvergne, A. Moktefi, M. Rabant, and et al. Membranous nephropathy associated with immunological disorder-related liver disease: a retrospective study of 10 cases Medicine (Baltimore) 94 30 2015 e1243
31. Q. Xie, Y. Li, J. Xue, and et al. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy Am J Nephrol 41 4-5 2015 345 353
32. E. Hoxha, S. Harendza, G. Zahner, and et al. An immunofluorescence test for phospholipase-A(2)-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis Nephrol Dial Transplant 26 8 2011 2526 2532
33. B. Svobodova, E. Honsova, P. Ronco, V. Tesar, and H. Debiec Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy Nephrol Dial Transplant 28 7 2013 1839 1844
34. J.M. Hofstra, and J.F. Wetzels Phospholipase A2 receptor antibodies in membranous nephropathy: unresolved issues J Am Soc Nephrol 25 6 2014 1137 1139
35. C.P. Larsen, N.C. Messias, F.G. Silva, E. Messias, and P.D. Walker Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies Mod Pathol 26 5 2013 709 715
36. M. Fresquet, T.A. Jowitt, J. Gummadova, and et al. Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy J Am Soc Nephrol 26 2 2015 302 313
37. A.E. van de Logt, J.M. Hofstra, and J.F. Wetzels Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up Kidney Int 87 6 2015 1263 1264
38. R. Ramachandran, V. Kumar, R. Nada, and V. Jha Serial monitoring of anti-PLA2R in initial PLA2R-negative patients with primary membranous nephropathy Kidney Int 88 5 2015 1198 1199
39. S.A. Timmermans, R. Ayalon, P. van Paassen, and et al. Anti-phospholipase A2 receptor antibodies and malignancy in membranous nephropathy Am J Kidney Dis 62 6 2013 1223 1225
40. Y.J. Oh, S.H. Yang, D.K. Kim, S.W. Kang, and Y.S. Kim Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy PLoS One 8 4 2013 e62151
41. L.H. Beck Jr., F.C. Fervenza, D.M. Beck, and et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy J Am Soc Nephrol 22 8 2011 1543 1550
42. J.M. Hofstra, H. Debiec, C.D. Short, and et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy J Am Soc Nephrol 23 10 2012 1735 1743
43. E. Hoxha, I. Thiele, G. Zahner, U. Panzer, S. Harendza, and R.A. Stahl Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy J Am Soc Nephrol 25 6 2014 1357 1366
44. P. Ruggenenti, H. Debiec, B. Ruggiero, and et al. Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy J Am Soc Nephrol 26 10 2015 2545 2558
45. L.H. Beck, F.C. Fervenza, D.M. Beck, R.G.B. Bonegio, S.B. Erickson, and D.J. Salant Association of anti-PLA2R antibody level with clinical response to rituximab in idiopathic membranous nephropathy [abstract] J Am Soc Nephrol 20 2009 3A 4A
46. A.P. Bech, J.M. Hofstra, P.E. Brenchley, and J.F. Wetzels Association of anti-PLA(2)R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy Clin J Am Soc Nephrol 9 8 2014 1386 1392
47. B. Seitz-Polski, G. Dolla, C. Payre, and et al. Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy Biochimie 118 2015 104 115
48. E. Hoxha, S. Harendza, H. Pinnschmidt, U. Panzer, and R.A. Stahl PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system PLoS One 9 10 2014 e110681
49. E. Hoxha, S. Harendza, H. Pinnschmidt, U. Panzer, and R.A. Stahl M-Type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy Clin J Am Soc Nephrol 9 11 2014 1883 1890
50. P.T. Klouda, J. Manos, E.J. Acheson, and et al. Strong association between idiopathic membranous nephropathy and HLA-DRW3 Lancet 2 8146 1979 770 771
51. J.C. Le Petit, B. Laurent, and F.C. Berthoux HLA-DR3 and idiopathic membranous nephritis (IMN) association Tissue Antigens 20 3 1982 227 228
52. R.W. Vaughan, A.G. Demaine, and K.I. Welsh A DQA1 allele is strongly associated with idiopathic membranous nephropathy Tissue Antigens 34 5 1989 261 269
53. S. Ogahara, S. Naito, K. Abe, I. Michinaga, and K. Arakawa Analysis of HLA class II genes in Japanese patients with idiopathic membranous glomerulonephritis Kidney Int 41 1 1992 175 182
54. D. Chevrier, M. Giral, R. Perrichot, and et al. Idiopathic and secondary membranous nephropathy and polymorphism at TAP1 and HLA-DMA loci Tissue Antigens 50 2 1997 164 169
55. S. Kim, H.J. Chin, K.Y. Na, and et al. Single nucleotide polymorphisms in the phospholipase A2 receptor gene are associated with genetic susceptibility to idiopathic membranous nephropathy Nephron Clin Pract 117 3 2011 c253 c258
56. Y.H. Liu, C.H. Chen, S.Y. Chen, and et al. Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan J Biomed Sci 17 2010 81
57. H.C. Stanescu, M. Arcos-Burgos, A. Medlar, and et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy N Engl J Med 364 7 2011 616 626
58. M.J. Coenen, J.M. Hofstra, H. Debiec, and et al. Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy J Am Soc Nephrol 24 4 2013 677 683
59. J. Lv, W. Hou, X. Zhou, and et al. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy J Am Soc Nephrol 24 8 2013 1323 1329
60. C.P. Larsen, M.L. Beggs, P.D. Walker, M. Saeed, J.M. Ambruzs, and N.C. Messias Histopathologic effect of APOL1 risk alleles in PLA2R-associated membranous glomerulopathy Am J Kidney Dis 64 1 2014 161 163
61. D.J. Salant Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy? J Am Soc Nephrol 24 4 2013 525 528
62. O. Llorca Extended and bent conformations of the mannose receptor family Cell Mol Life Sci 65 9 2008 1302 1310
63. L. Kao, V. Lam, M. Waldman, R.J. Glassock, and Q. Zhu Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy J Am Soc Nephrol 26 2 2015 291 301
64. L.H. Beck, D.G. Sandor, H. Ma, and D.J. Salant Identification of distinct dominant and subdominant humoral epitopes within PLA2R1 in primary membranous nephropathy [abstract] J Am Soc Nephrol 25 2014 17A
65. Seitz-Polski B, Dolla G, Payré C, et al. Epitope spreading in PLA2R1 is associated with bad prognosis in membranous nephropathy [published online ahead of print November 13, 2015]. J Am Soc Nephrol. http://dx.doi.org/10.1681/ASN.2014111061.
66. J.P. Cosyns, C. Couchoud, C. Pouteil-Noble, J.P. Squifflet, and Y. Pirson Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors Clin Nephrol 50 3 1998 144 153
67. M.A. Josephson, B. Spargo, D. Hollandsworth, and J.R. Thistlethwaite The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: case report and literature review Am J Kidney Dis 24 5 1994 873 878
68. J. Floege Recurrent glomerulonephritis following renal transplantation: an update Nephrol Dial Transplant 18 7 2003 1260 1265
69. G. Moroni, B. Gallelli, S. Quaglini, and et al. Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN) Nephrol Dial Transplant 25 10 2010 3408 3415
70. T.S. Dabade, J.P. Grande, S.M. Norby, F.C. Fervenza, and F.G. Cosio Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study Am J Transplant 8 6 2008 1318 1322
71. Z.M. El-Zoghby, J.P. Grande, M.G. Fraile, S.M. Norby, F.C. Fervenza, and F.G. Cosio Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies Am J Transplant 9 12 2009 2800 2807
72. J. Floege, H. Regele, L. Gesualdo ERA-EDTA Immunonephrology Working Group The ERA-EDTA database on recurrent glomerulonephritis following renal transplantation Nephrol Dial Transplant 29 1 2014 15 21
73. R. Stahl, E. Hoxha, and K. Fechner PLA2R autoantibodies and recurrent membranous nephropathy after transplantation N Engl J Med 363 5 2010 496 498
74. H. Debiec, L. Martin, C. Jouanneau, and et al. Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy Am J Transplant 11 10 2011 2144 2152
75. C.D. Blosser, R. Ayalon, R. Nair, C. Thomas, and L.H. Beck Jr. Very early recurrence of anti-phospholipase A2 receptor-positive membranous nephropathy after transplantation Am J Transplant 12 6 2012 1637 1642
76. A. Kattah, R. Ayalon, L.H. Beck Jr., and et al. Anti-phospholipase A(2) receptor antibodies in recurrent membranous nephropathy Am J Transplant 15 5 2015 1349 1359
77. L.F. Quintana, M. Blasco, M. Seras, and et al. Antiphospholipase A2 receptor antibody levels predict the risk of posttransplantation recurrence of membranous nephropathy Transplantation 99 8 2015 1709 1714
78. B. Seitz-Polski, C. Payre, D. Ambrosetti, and et al. Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: a case series of 15 patients Nephrol Dial Transplant 29 12 2014 2334 2342
79. M.B. Andresdottir, and J.F. Wetzels Increased risk of recurrence of membranous nephropathy after related donor kidney transplantation Am J Transplant 12 1 2012 265 266
80. M. El Kossi, A. Harmer, J. Goodwin, and et al. De novo membranous nephropathy associated with donor-specific alloantibody Clin Transplant 22 1 2008 124 127
81. K. Honda, S. Horita, D. Toki, and et al. De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney Clin Transplant 25 2 2011 191 200
82. B.J. Lim, M.S. Kim, Y.S. Kim, S.I. Kim, and H.J. Jeong C4d deposition and multilayering of peritubular capillary basement membrane in posttransplantation membranous nephropathy indicate its association with antibody-mediated injury Transplant Proc 44 3 2012 619 620
83. C. Ponticelli, and R.J. Glassock De novo membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease? Transpl Int 25 12 2012 1205 1210
84. C.P. Larsen, and P.D. Walker Phospholipase A2 receptor (PLA2R) staining is useful in the determination of de novo versus recurrent membranous glomerulopathy Transplantation 95 10 2013 1259 1262